Breast cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who meet all of the following 1. Diagnosis as a carrier of a clinically actionable germline pathogenic/likely pathogenic genetic mutation (BRCA1, BRCA2, ATM, CDH1, CHEK2, NBN, NF1, PALB2, PTEN, STK11, TP53, BRIP1, MSH2, MLH1, MSH6, PMS2, EPCAM, RAD51C, RAD51D, RYR2, RB1)in the previous study(Kyoto University Ethical Committe G424) 2. Regular follow-up in the participating hospitals 3. Consent to disclosure of the research results, genetic counseling and this study
Exclusion criteria
Exclusion criteria: Patients who meet one of the following 1. Lost to follow-up 2. Declining disclosure of the research results, genetic counseling, or participation in this study 3. Previous genetic counseling and diagnosis as a carrier on clinical genetic testing
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The change in GCOS-24 score between before and after genetic counseling (GCOS-24:The Genetic Counseling Outcome Scale) | — |
Secondary
| Measure | Time frame |
|---|---|
| Associations between the changes in GCOS-24 scores and patient factors | — |
Countries
Japan
Contacts
Kyoto University Hospital Clinical Oncology